: iStockAnalyst.com Symbols Feed

10 Stocks That You Absolutely Positively Definitely Have To Know About

Tue, 30 Dec 2008 17:27:00 GMT

The following was sent to TIMalert subscribers at 3AM EST..yah nobody works as hard as me…100 hour workweek baby! Don’t forget this is your second to last day to take advantage of the holiday... Visit TimothySykes.com to read full article with comments [More...]

9 Stocks Blah Blah Blah, You Don’t Even Know How To Short Sell Them Do You?

Mon, 29 Dec 2008 17:42:00 GMT

This was sent to TIMalert subscribers late late late last night…if you want to have any idea on how to trade these volatile suckers, watch my instructional DVDs please: Some mighty fine setups... Visit TimothySykes.com to read full article with comments [More...]

Proteonomix, Inc. (PROT) Announces the Appointment of Robert Kohn as Acting CFO

Wed, 19 Aug 2009 13:27:00 GMT

MOUNTAINSIDE, NJ -- -- 08/19/09 -- Proteonomix, Inc. announces that Robert Kohn has joined the Company as acting CFO.[More...]

Proteonomix, Inc. (PROT) Files a Registration Statement With the USSEC on Form 10 to Become a Reporting Company -- the Gateway to the Trading of Its Common Stock on the OTC Bulletin Board

Tue, 04 Aug 2009 14:40:00 GMT

MOUNTAINSIDE, NJ -- -- 08/04/09 -- Proteonomix, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission on Form 10. Its shares can trade on the Over the Counter Bulletin Board when the registration statement is effective and FINRA grants clearance.[More...]

Proteonomix, Inc. (PROT) Announces Definitive Agreement for Sale of Its Stem Cell Derived Cosmeceutical Products With Two Companies Headquartered in China

Tue, 10 Feb 2009 14:59:00 GMT

MOUNTAINSIDE, NJ -- -- 02/10/09 -- Proteonomix, Inc. announces that it and its subsidiary, Proteoderm, Inc., have entered into a renewable three-year contract. This definitive agreement is a follow up of a letter of intent dated December 15, 2008 with two China-based companies, China Biopharma, Inc. and Sinoquest Investment Limited, for the exclusive license, ingredient purchase, sale and distribution of Proteoderm's stem cell-derived cosmeceutical product lines in China, Hong Kong and Taiwan.[More...]

/ CORRECTION - Proteonomix, Inc. (PROT) Announces the Appointment of Terry Dubrow, M.D., a Noted Plastic Surgeon and Participant in the Fox Make-Over Reality Show "The Swan," as a Consultant to the Company and Its Subsidiary, Proteoderm, Inc.

Thu, 29 Jan 2009 19:54:00 GMT

MOUNTAINSIDE, NJ -- -- 01/29/09 -- In the news release, 'Proteonomix, Inc. Announces the Appointment of Terry Dubrow, M.D., a Noted Plastic Surgeon and Participant in the Fox Make-Over Reality Show 'The Swan,' as a Consultant to the Company and Its Subsidiary, Proteoderm, Inc.,' issued earlier today by Proteonomix, Inc. , please be advised that the first sentence of the first paragraph should read 'Proteonomix, Inc. has announced that Terry Dubrow, M.D. has joined the Company as a consultant to represent it and Proteoderm, Inc., its subsidiary, as its medical spokesperson.' rather than 'Proteonomix, Inc. has announced that Terry Dubrow, M.D. has joined the Company as a consultant to represent the it and Proteoderm, Inc., its subsidiary, as its medical spokesperson.' as originally issued incorrectly by Marketwire. Complete corrected text follows.[More...]

Proteonomix, Inc. (PROT) Announces the Appointment of Terry Dubrow, M.D., a Noted Plastic Surgeon and Participant in the Fox Make-Over Reality Show "The Swan," as a Consultant to the Company and Its Subsidiary, Proteoderm, Inc.

Thu, 29 Jan 2009 17:56:00 GMT

MOUNTAINSIDE, NJ -- -- 01/29/09 -- Proteonomix, Inc. has announced that Terry Dubrow, M.D. has joined the Company as a consultant to represent the it and Proteoderm, Inc., its subsidiary, as its medical spokesperson.[More...]

Proteonomix, Inc. (PROT) Announces the Appointment of Clifford Miller, Chief Executive Officer of Andrew Martin Company, as Our Consultant in Cosmetic Packaging and Marketing

Tue, 27 Jan 2009 17:40:00 GMT

MOUNTAINSIDE, NJ -- -- 01/27/09 -- Proteonomix, Inc. announces the appointment of Clifford Miller as cosmetic packaging and marketing consultant for its subsidiary, Proteoderm, Inc.[More...]

Proteonomix, Inc. (PROT) Announces the Effectiveness of the Appointment of Steven Byle to Its Board of Directors

Fri, 16 Jan 2009 16:17:00 GMT

MOUNTAINSIDE, NJ -- -- 01/16/09 -- Proteonomix, Inc. announces that Steven Byle has commenced his tenure on its board of directors.[More...]

Proteonomix, Inc. (PROT) Announces the Appointment of Steven Byle to Its Board of Directors

Mon, 05 Jan 2009 13:10:00 GMT

MOUNTAINSIDE, NJ -- -- 01/05/09 -- Proteonomix, Inc. announces the appointment of Steven Byle to its Board of Directors effective January 15, 2009.[More...]

Proteonomix, Inc. Announces the Publication of Research on Use of Umbilical Cord Blood in Growing Undifferentiated Embryonic Stem Cells

Thu, 18 Dec 2008 14:02:00 GMT

MOUNTAINSIDE, NJ -- -- 12/18/08 -- Proteonomix, Inc. announces the publication in Cloning and Stem Cells Journal Volume 10 No. 4, published on November 20, 2008 by Mary Ann Liebert, Inc., of an article entitled 'Cells Derived from Human Umbilical Cord Blood Support the Long-Term Growth of Undifferentiated Human Embryonic Stem Cells.'[More...]

Proteonomix, Inc. Announces That Its Subsidiary, Proteoderm, Inc., Has Entered Into a Letter of Intent With Sinoquest Investment Limited for the Licensing, Purchase and Distribution of Proteoderm's Cosmoceutical Containing Its Patent-Pending Bioactive Protein Matrix

Mon, 15 Dec 2008 16:54:00 GMT

MOUNTAINSIDE, NJ -- -- 12/15/08 -- Proteonomix, Inc. announces that its wholly-owned subsidiary, Proteoderm, Inc., and Sinoquest Investment Limited have signed a letter of intent , whereby, under a definitive agreement to be consummated, Sinoquest will gain exclusive rights in China, Taiwan, and Hong Kong to purchase for distribution of Proteoderm's revolutionary new stem cell-derived skin care products containing the bioactive protein matrix NC-138. The products include Proteoderm's special high end formulation and an over-the-counter formulation, currently under development. Proteoderm intends to sell to Sinoquest the pre-mixed material in bulk and a license of its name and the right to use the material in Sinoquest's own containers. Both companies expect to begin distribution in the first quarter of 2009.[More...]